{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:35:33Z","timestamp":1790620533925,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"abstract":"\n Importance<\/jats:title>\n Current treatment for type 1 retinopathy of prematurity (ROP), including laser photocoagulation and intravitreal anti\u2013vascular endothelial growth factor therapy, is invasive but necessary to prevent blindness. Experimental evidence and limited clinical experience suggest that topical steroids may reduce disease progression and the need for invasive treatment.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate whether dexamethasone eye drops reduce the proportion of preterm infants with prethreshold ROP progressing to treatment-requiring type 1 ROP.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n The DROPROP trial was a double-masked randomized clinical trial at 6 university hospitals and 8 county hospitals in Sweden. It evaluated infants born before 30 weeks\u2019 gestational age (GA), from 2022 to 2025, with severe ROP. Data analysis was performed from November 2025 to January 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Infants were randomized to receive dexamethasone eye drops (1 mg\/mL) or placebo (saline). One eye drop was administered every day or every other day for up to 12 weeks.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was progression to type 1 ROP requiring invasive treatment. Logistic regression adjusted for GA and site was used for the primary analysis. Intention-to-treat analysis was performed. Adverse events were monitored as safety outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 100 infants, the mean (SD) GA at birth was 25.1 (1.4) weeks, 42 (42.0%) were female, and the mean (SD) birth weight was 712.9 (202.1) g. In the intention-to-treat population, type 1 ROP occurred in 10 of 50 infants (20.0%) in the dexamethasone group and 19 of 50 infants (38.0%) in the placebo group (adjusted odds ratio, 0.44; 95% CI, 0.17-1.12;\n P<\/jats:italic>\n \u2009=\u2009.08), corresponding to a relative risk reduction of 47%. In the per-protocol population, type 1 ROP occurred in 9 of 48 infants (18.8%) in the dexamethasone group vs 19 of 49 infants (38.8%) in the placebo group (adjusted odds ratio, 0.40; 95% CI 0.15-1.05). No clinically significant differences in adverse events were observed between groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Timely administration of topical dexamethasone numerically reduced the risk of prethreshold ROP progressing to treatment-requiring type 1 ROP. Although the analysis did not reach statistical significance, these findings suggest that topical dexamethasone may be a safe, noninvasive strategy to reduce the need for invasive treatment.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n euclinicaltrials.eu Identifier:\n 2023-505318-97-00<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.3247","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:00:21Z","timestamp":1785769221000},"source":"Crossref","is-referenced-by-count":2,"title":["Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity"],"prefix":"10.1001","author":[{"given":"Ann","family":"Hellstr\u00f6m","sequence":"first","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Petrishka-Lozenska","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Sj\u00f6bom","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"},{"name":"Learning and Leadership for Health Care Professionals, Institute of Health and Care Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Wallander","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Region J\u00f6nk\u00f6ping County, J\u00f6nk\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders K.","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatarina","family":"L\u00f6fqvist","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Learning and Leadership for Health Care Professionals, Institute of Health and Care Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ley","sequence":"additional","affiliation":[{"name":"Pediatrics, Department of Clinical Sciences, Lund, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Gr\u00e4nse","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Clinical Sciences, Lund, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna Maria","family":"\u00d6hnell","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Clinical Sciences, Lund, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"H\u00e5rd","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Jakobsson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"S\u00e4vman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Neonatology, Region V\u00e4stra G\u00f6taland, The Queen Silvia Children\u2019s Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Domell\u00f6f","sequence":"additional","affiliation":[{"name":"Pediatrics, Department of Clinical Sciences, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"L\u00f6fgren","sequence":"additional","affiliation":[{"name":"Department of Paediatric Ophthalmology, Strabismus and Electrophysiology, St Erik Eye Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E.H.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Lundgren","sequence":"additional","affiliation":[{"name":"Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Ophthalmology, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DROPROP Collaboration Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Vallin","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hansen-Pupp","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Te\u00e4r Fahnehjelm","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Albinsson","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Normann","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alibakhshi","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikica","family":"Toma\u0161i\u0107","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Ingemansson","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Mirabelli","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Odelberg","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Tsamadou","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Tsigkoulis","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kopparstr\u00f6m","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Eriksson","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hochard Sandgren","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterni","family":"Massou","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Friberg-Riad","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Skriapa-Manta","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Lind","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Lid\u00e9n","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn\u00e9a","family":"Holmberg","sequence":"additional","affiliation":[{"name":"for the DROPROP Collaboration Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"poi260046r1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births.","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"issue":"6","key":"poi260046r2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1053\/j.semperi.2019.05.002","article-title":"Epidemiology of ROP update\u2014Africa is the new frontier.","volume":"43","author":"Gilbert","year":"2019","journal-title":"Semin Perinatol"},{"issue":"8","key":"poi260046r3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/apa.16354","article-title":"National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidity.","volume":"111","author":"Lundgren","year":"2022","journal-title":"Acta Paediatr"},{"key":"poi260046r4","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.3346\/jkms.2015.30.S1.S25","article-title":"Changes in survival rate for very-low-birth-weight infants in Korea: comparison with other countries.","volume":"30","author":"Shim","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"8","key":"poi260046r5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapediatrics.2022.1622","article-title":"Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019.","volume":"176","author":"Cao","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"3","key":"poi260046r6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of prematurity: a global perspective and recent developments.","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"issue":"9902","key":"poi260046r7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity.","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"poi260046r8","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1167\/iovs.17-21931","article-title":"Systemic inflammation-associated proteins and retinopathy of prematurity in infants born before the 28th week of gestation.","volume":"58","author":"Holm","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"poi260046r9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/bjophthalmol-2019-314874","article-title":"New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register.","volume":"104","author":"Holmstr\u00f6m","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"poi260046r10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"poi260046r11","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition.","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"issue":"7","key":"poi260046r12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited.","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"poi260046r13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/ICU.0000000000000783","article-title":"Complications of retinopathy of prematurity treatment.","volume":"32","author":"Barnett","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"poi260046r14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009734.pub3","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"poi260046r15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1502047","article-title":"Ophthalmic corticosteroids-related adverse events: the FDA Adverse Event Reporting System (FAERS) database pharmacovigilance study.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"poi260046r16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ophtha.2025.09.020","article-title":"Treating retinopathy of prematurity with dexamethasone eye drops: a difference-in-differences study in Sweden using register data.","volume":"133","author":"Gr\u00e4nse","year":"2026","journal-title":"Ophthalmology"},{"issue":"4","key":"poi260046r17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10456-024-09948-2","article-title":"Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity.","volume":"27","author":"Yagi","year":"2024","journal-title":"Angiogenesis"},{"issue":"2","key":"poi260046r18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.oret.2021.09.002","article-title":"Dexamethasone eye drops for the treatment of retinopathy of prematurity.","volume":"6","author":"\u00d6hnell","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"poi260046r19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1203\/00006450-199907000-00016","article-title":"Dexamethasone reduces oxygen induced retinopathy in a mouse model.","volume":"46","author":"Rotschild","year":"1999","journal-title":"Pediatr Res"},{"issue":"10","key":"poi260046r20","first-page":"3095","article-title":"Dexamethasone and critical effect of timing on retinopathy.","volume":"41","author":"Yossuck","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"poi260046r21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12887-025-05673-x","article-title":"Evaluation of timed dexamethasone eye drops to prevent proliferative retinopathy of prematurity: a study protocol for a randomized intervention, multi-centre, double-blinded trial (DROPROP).","volume":"25","author":"Hellstr\u00f6m","year":"2025","journal-title":"BMC Pediatr"},{"issue":"22","key":"poi260046r22","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"14","key":"poi260046r23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments.","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"poi260046r24","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective.","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"poi260046r25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamaophthalmol.2025.5594","article-title":"Proteomic profile in retinopathy of prematurity: a secondary analysis of the Mega Donna Mega randomized clinical trial.","volume":"144","author":"Lundgren","year":"2026","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"poi260046r26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1053\/j.semperi.2009.07.003","article-title":"Ethical issues in research involving infants.","volume":"33","author":"Diekema","year":"2009","journal-title":"Semin Perinatol"},{"issue":"10","key":"poi260046r27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/archdischild-2014-306444","article-title":"Guidance on clinical research involving infants, children and young people: an update for researchers and research ethics committees.","volume":"99","author":"Modi","year":"2014","journal-title":"Arch Dis Child"},{"issue":"4","key":"poi260046r28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.semperi.2015.12.014","article-title":"Ethical issues in neonatal research involving human subjects.","volume":"40","author":"Fleischman","year":"2016","journal-title":"Semin Perinatol"},{"issue":"2","key":"poi260046r29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archopht.1968.03850040176013","article-title":"Systemic absorption of topical steroids.","volume":"79","author":"Burch","year":"1968","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"poi260046r30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/aos.15253","article-title":"Prevalence and risk factors for hypothalamus-pituitary-adrenal axis suppression in infants receiving glucocorticoid eye drops after ocular surgery.","volume":"101","author":"Schmidt","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"poi260046r31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks.","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"issue":"10","key":"poi260046r32","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ophtha.2018.04.035","article-title":"Adrenal suppression in infants treated with topical ocular glucocorticoids.","volume":"125","author":"Bangsgaard","year":"2018","journal-title":"Ophthalmology"},{"key":"poi260046r33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.earlhumdev.2015.10.019","article-title":"Mortality and morbidity risks vary with birth weight standard deviation score in growth restricted extremely preterm infants.","volume":"92","author":"Yamakawa","year":"2016","journal-title":"Early Hum Dev"},{"issue":"6","key":"poi260046r34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.semperi.2019.05.012","article-title":"Retinopathy of prematurity, visual and neurodevelopmental outcome, and imaging of the central nervous system.","volume":"43","author":"Morken","year":"2019","journal-title":"Semin Perinatol"},{"key":"poi260046r35","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1055813","article-title":"Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: a systematic review and meta-analysis.","volume":"11","author":"Diggikar","year":"2023","journal-title":"Front Pediatr"},{"issue":"5","key":"poi260046r36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41390-020-1030-3","article-title":"Surgery requiring general anesthesia in preterm infants is associated with altered brain volumes at term equivalent age and neurodevelopmental impairment.","volume":"89","author":"Walsh","year":"2021","journal-title":"Pediatr Res"},{"issue":"7","key":"poi260046r37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/eye.2012.111","article-title":"Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity.","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"issue":"4","key":"poi260046r38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ophtha.2018.12.012","article-title":"Laser treatment for retinopathy of prematurity: a decade since ETROP.","volume":"126","author":"Emami","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"poi260046r39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000543659","article-title":"Association between early postnatal hydrocortisone and retinopathy of prematurity in extremely preterm infants.","volume":"122","author":"Petrishka-Lozenska","year":"2025","journal-title":"Neonatology"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2852525\/jamapediatrics_hellstrm_2026_oi_260046_1788550184.05003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:02:26Z","timestamp":1789398146000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2852525"}},"subtitle":["The DROPROP Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.3247","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}